Updated Jul 16, 2026
Taylor Ben R has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $68K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 5.4K | $3.15 | $17K |
| 2026-05-19 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 25.0K | $3.04 | $76K |
| 2026-04-08 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 48.0K | $3.11 | $149K |
| 2026-03-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 8.0K | $3.39 | $27K |
| 2026-03-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture [10b5-1] | 7.1K | $3.42 | $24K |
| 2026-02-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 13.4K | $3.08 | $41K |
| 2026-02-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture [10b5-1] | 11.9K | $3.49 | $42K |
| 2026-02-10 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 11.4K | $3.98 | $45K |
| 2026-02-10 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 24.3K | $0.00 | |
| 2026-02-10 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 446.3K | $0.00 | |
| 2025-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 7.1K | $4.83 | $34K |
| 2025-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 11.9K | $5.64 | $67K |
| 2024-12-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 370.3K | $0.00 | |
| 2024-12-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 7.1K | $6.95 | $49K |
| 2024-12-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 15.7K | $6.04 | $95K |
Taylor Ben R is a corporate insider — currently tracked as Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($68K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Taylor Ben R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.